These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 324566)

  • 1. Intravenous tyramine response in migraine before and during treatment with indoramin.
    Ghose K; Coppen A; Carrol D
    Br Med J; 1977 May; 1(6070):1191-3. PubMed ID: 324566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term trial of an alpha adrenoceptor blocking drug (Indoramin) in asthma. A preliminary report.
    Black JL; Temple DM; Anderson SD
    Scand J Respir Dis; 1978; 59(6):307-12. PubMed ID: 373090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of tyramine-induced migraine: similarity with dopamine and interactions with disulfiram and propranolol in migraine patients.
    Ghose K; Carroll JD
    Neuropsychobiology; 1984; 12(2-3):122-6. PubMed ID: 6527752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine].
    Pradalier A; Dry J; Loisy B; Meininger V; Vicaut E; Mirabaud C; Levy M
    Therapie; 1988; 43(4):293-7. PubMed ID: 3055407
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Indoramin in prevention of migraine.
    Wainscott G; Volans GN; Wilkinson M; Faux GA
    Lancet; 1975 Jul; 2(7923):32-3. PubMed ID: 49624
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-adrenoreceptor blockade with indoramin in hypertension.
    Gould BA; Mann S; Davies AB; Altman DG; Raftery EB
    J Cardiovasc Pharmacol; 1983; 5(3):343-8. PubMed ID: 6191130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
    Stannard M; Cohen M; Marrott PK; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of an alpha-adrenoreceptor blocking drug (indoramin) in exercise-induced bronchoconstriction.
    Seale JP; Anderson SD; Lindsay DA
    Scand J Respir Dis; 1976; 57(6):261-6. PubMed ID: 189384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic dose-response effects of intravenous indoramin in acute heart failure complicating myocardial infarction.
    Silke B; Nelson GI; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S102-6. PubMed ID: 2423781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of ejaculation with indoramin.
    Pentland B; Anderson DA; Critchley JA
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1433-4. PubMed ID: 6784854
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
    Grube E; Giesing M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S43-7. PubMed ID: 2423796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indoramin on finger circulation in patients with Raynaud disease.
    Clement DL; Duprez D; De Pue N
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S84-7. PubMed ID: 2423806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of indoramin on exercise performance in mild hypertension.
    Bishop N; Mackintosh AF; Stoker JB; Mary DA; Linden RJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S30-6. PubMed ID: 2423794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of indoramin and methyldopa in hypertension.
    Rosendorff C
    S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive therapy with indoramin in the elderly.
    Deitch MW; Allen IE; Pascucci VL
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyramine pressor test: implications and limitations.
    Ghose K
    Methods Find Exp Clin Pharmacol; 1984 Aug; 6(8):455-64. PubMed ID: 6492942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.